Kontrowersyjna decyzja wycofania dapagliflozyny w Unii Europejskiej
07.01.2022
medscape.com/viewarticle/964844
jdrf.org/press-releases/jdrf-international-voices-disappointment-as-drug-for-type-1-diabetes-is-withdrawn-by-astrazeneca/
hpra.ie/docs/default-source/default-document-library/important-safety-information-forxiga-(dapagliflozin)-5mg.pdf?sfvrsn=0